Methemoglobinemia and hemolytic anemia caused by rasburicase administration in a newly diagnosed child with Burkitt lymphoma/leukemia.
Borinstein
Scott C
SC
Xu
Min
M
Hawkins
Douglas S
DS
D000293:Adolescent; D000743:Anemia, Hemolytic / Q000139:chemically induced*; D002051:Burkitt Lymphoma / Q000150:complications*; D005953:Glycogen Storage Disease Type I / Q000150:complications; D006801:Humans; D033461:Hyperuricemia / Q000188:drug therapy / Q000209:etiology; D008297:Male; D008708:Methemoglobinemia / Q000139:chemically induced*; D011994:Recombinant Proteins / Q000009:adverse effects; D014503:Urate Oxidase / Q000009:adverse effects* / Q000627:therapeutic use
D011994:Recombinant Proteins; C469709:rasburicase; D014503:Urate Oxidase